drug discovery, idrug engineering, type ii diabetes, diabetes, cardiovascular disease, hiv, clinical trials, drug discovery services, medicinal chemistry, hit to lead, hit identification, admet, numerate, discovery

numerate is a small molecule therapeutics company with a proprietary drug engineering process that rapidly and cost-effectively delivers compounds optimized for improved efficacy, safety, and patentability. numerate#s therapeutic pipeline includes a multi-targeted therapy for type ii diabetes and cardiovascular disease, as well as a new, more versatile drug for hiv therapy. numerate also applies its technology to design and develop small molecule drugs in collaboration with a variety of partners, rapidly delivering novel leads and shortening the timelines needed to advance programs into clinical trials.